Subject(s)

Precision Medicine , von Willebrand Diseases/diagnosis , von Willebrand Diseases/genetics , Adult , Age Factors , Aged , Child , Comorbidity , DNA Mutational Analysis , Female , Genetic Carrier Screening , Heart Diseases/blood , Heart Diseases/complications , Heart Diseases/diagnosis , Heart Diseases/therapy , Hemorrhage/prevention & control , Humans , Middle Aged , Pregnancy , Pregnancy Complications, Hematologic/blood , Pregnancy Complications, Hematologic/diagnosis , Pregnancy Complications, Hematologic/genetics , Pregnancy Complications, Hematologic/therapy , Risk Factors , Thrombosis/prevention & control , von Willebrand Diseases/blood , von Willebrand Diseases/therapy , von Willebrand Factor/genetics , von Willebrand Factor/metabolism , von Willebrand Factor/therapeutic use

Subject(s)

Benzhydryl Compounds/therapeutic use , Cardiovascular Diseases/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Glucosides/therapeutic use , Cardiovascular Diseases/mortality , Diabetes Mellitus, Type 2/mortality , Dose-Response Relationship, Drug , Humans , Risk Factors , Survival Rate

Subject(s)

Anticoagulants/adverse effects , Anxiety/psychology , Atrial Fibrillation/drug therapy , Atrial Fibrillation/psychology , Hemorrhage/chemically induced , Hemorrhage/psychology , Administration, Oral , Anticoagulants/therapeutic use , Drug Approval , Humans , Risk , Vitamin K/antagonists & inhibitors

Subject(s)

Asthma/diagnosis , Pulmonary Disease, Chronic Obstructive/diagnosis , Asthma/drug therapy , Budesonide/administration & dosage , Comorbidity , Drug Combinations , Dry Powder Inhalers , Formoterol Fumarate/administration & dosage

Subject(s)

Anticoagulants/therapeutic use , Morpholines/therapeutic use , Pulmonary Embolism/classification , Pulmonary Embolism/drug therapy , Thiophenes/therapeutic use , Acute Disease , Guideline Adherence , Heparin/therapeutic use , Humans , Risk Assessment , Rivaroxaban , Vitamin K/antagonists & inhibitors

Subject(s)

Guideline Adherence , Mass Screening , Prostatic Neoplasms/diagnosis , Aged , Algorithms , Biomarkers, Tumor/blood , Early Diagnosis , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Predictive Value of Tests , Prostate/pathology , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Survival Rate

Subject(s)

Erectile Dysfunction/rehabilitation , Phosphodiesterase 5 Inhibitors/therapeutic use , Postoperative Complications/rehabilitation , Prostatectomy/rehabilitation , Prostatic Neoplasms/surgery , Aged , Drug Administration Schedule , Humans , Male , Middle Aged , Penile Prosthesis

Subject(s)

Libido , Sexual Dysfunction, Physiological , Adult , Benzimidazoles/administration & dosage , Benzimidazoles/therapeutic use , Controlled Clinical Trials as Topic , Dyspareunia/drug therapy , Female , Humans , Middle Aged , Postmenopause , Sexual Dysfunction, Physiological/drug therapy , Surveys and Questionnaires , United States , United States Food and Drug Administration , Vaginismus/drug therapy

Subject(s)

Depression, Postpartum , Depression , Mothers , Pregnancy Complications , Antidepressive Agents/administration & dosage , Antidepressive Agents/therapeutic use , Depression/drug therapy , Depression/psychology , Depression/therapy , Depression, Postpartum/drug therapy , Depression, Postpartum/psychology , Depression, Postpartum/therapy , Female , Humans , Infant, Newborn , Male , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Complications/psychology , Pregnancy Complications/therapy , Psychotherapy

Subject(s)

Testosterone/deficiency , Andropause , Diabetes Mellitus/blood , Guidelines as Topic , Hematocrit , Hematopoiesis , Humans , Libido , Male , Metabolic Syndrome/etiology , Obesity/etiology , Syndrome , Testosterone/administration & dosage , Testosterone/blood , Testosterone/therapeutic use

Subject(s)

Antidepressive Agents/therapeutic use , Behavior Therapy , Depressive Disorder/therapy , Psychotherapy , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adult , Antidepressive Agents/administration & dosage , Antidepressive Agents, Second-Generation/administration & dosage , Antidepressive Agents, Second-Generation/therapeutic use , Combined Modality Therapy , Cyclohexanols/administration & dosage , Cyclohexanols/therapeutic use , Depressive Disorder/diagnosis , Depressive Disorder/drug therapy , Depressive Disorder/genetics , Dopamine Uptake Inhibitors/administration & dosage , Dopamine Uptake Inhibitors/therapeutic use , Duloxetine Hydrochloride , Humans , Mianserin/administration & dosage , Mianserin/analogs & derivatives , Mianserin/therapeutic use , Middle Aged , Mirtazapine , Selective Serotonin Reuptake Inhibitors/administration & dosage , Thiophenes/administration & dosage , Thiophenes/therapeutic use , Venlafaxine Hydrochloride

Subject(s)

Angiotensin II Type 1 Receptor Blockers/therapeutic use , Benzimidazoles/therapeutic use , Benzoates/therapeutic use , Cardiovascular Diseases/prevention & control , Impotence, Vasculogenic/drug therapy , Impotence, Vasculogenic/etiology , Atherosclerosis/drug therapy , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/etiology , Humans , Male , Randomized Controlled Trials as Topic , Risk Factors , Telmisartan

Subject(s)

Anti-Bacterial Agents/therapeutic use , Otitis Externa/drug therapy , Sinusitis/drug therapy , Acute Disease , Adult , Bacterial Infections/diagnosis , Bacterial Infections/drug therapy , Child , Child, Preschool , Diabetes Complications/drug therapy , Diabetes Complications/microbiology , Humans , Infant , Otitis Externa/etiology , Otitis Externa/microbiology , Otitis Media/drug therapy , Otitis Media/microbiology , Recurrence , Sinusitis/etiology , Sinusitis/microbiology

Subject(s)

Arthritis, Rheumatoid/drug therapy , Immunosuppressive Agents/adverse effects , Opportunistic Infections/immunology , Vaccination , Vaccines/adverse effects , Arthritis, Rheumatoid/immunology , Contraindications , Humans , Immunization Schedule , Immunosuppressive Agents/immunology , Opportunistic Infections/prevention & control , Vaccines/immunology